YDES · Company research

YD Bio Limited Ordinary Shares (YDES): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

13records availableHealthcare

Stock News & Events data

Database-backed records only

13 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness ProgramsYD Bio and its affiliate EG BioMed have partnered with digital health provider JoiiUp to integrate an AI-driven cancer risk assessment tool into JoiiUp's JoiiSports app. The assessment, validated using over 1,200 clinical records from Taipei Medical University hospitals, analyzes demographic data and lifestyle factors across ten cancer types without requiring invasive testing. The tool will initially target corporate wellness programs through JoiiUp's network of 400+ companies, with planned expansion to healthcare institutions.View source ↗GlobeNewswire Inc.Oct 20, 2026bullish11
YD Bio Limited Ordinary Shares (YDES) Stock Price: Oct 7 Close $5.88 - GotradeYD Bio Limited Ordinary Shares (YDES) Stock Price: Oct 7 Close $5.88 GotradeView source ↗GotradeOct 8, 2026neutral00.6
Quarterly stock vesting brings Kochi Chang's direct YD Bio (YDES) holding to 10,965 shares. - Stock TitanQuarterly stock vesting brings Kochi Chang's direct YD Bio (YDES) holding to 10,965 shares. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
A survey that takes about 10 minutes returns risk reports for 10 cancers, without a blood draw or clinic visit. - Stock TitanA survey that takes about 10 minutes returns risk reports for 10 cancers, without a blood draw or clinic visit. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
$YDES stock is down 12% today. Here's what we see in our data. - Quiver Quantitative$YDES stock is down 12% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeOct 5, 2026neutral00.6
$YDES stock is down 9% today. Here's what we see in our data. - Quiver Quantitative$YDES stock is down 9% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeSep 17, 2026neutral00.6
Top YD Bio (YDES) Competitors 2026 - MarketBeatTop YD Bio (YDES) Competitors 2026 MarketBeatView source ↗MarketBeatSep 14, 2026neutral00.6
YD Bio Limited (YDES) Edges Higher as Shares Hold Above Key Support - Price Momentum Stocks - https://www.dars.gov.et/YD Bio Limited (YDES) Edges Higher as Shares Hold Above Key Support - Price Momentum Stocks https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Sep 4, 2026neutral00.6
YD Bio Limited (YDES) Edges Higher as Shares Hold Above Key Support - MACD Signal Stocks - www.dars.gov.etYD Bio Limited (YDES) Edges Higher as Shares Hold Above Key Support - MACD Signal Stocks www.dars.gov.etView source ↗www.dars.gov.etSep 4, 2026neutral00.6
YD Bio Ltd (YDES) Recent Insider Transactions - Yahoo Finance - Yahoo! Finance CanadaYD Bio Ltd (YDES) Recent Insider Transactions - Yahoo Finance Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaJan 7, 2026neutral00.6
YD Bio (YDES) Stock Price, News & Analysis - MarketBeatYD Bio (YDES) Stock Price, News & Analysis MarketBeatView source ↗MarketBeatDec 24, 2025neutral00.6
What is the current Price Target and Forecast for YD Bio Limited (YDES) - Zacks Investment ResearchWhat is the current Price Target and Forecast for YD Bio Limited (YDES) Zacks Investment ResearchView source ↗Zacks Investment ResearchNov 24, 2025neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNAug 30, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.